The Clorox Company (LON:0I0J)
London · Delayed Price · Currency is GBP · Price in USD | Market Cap | 9.69B -14.6% |
| Revenue (ttm) | 5.06B -5.4% |
| Net Income | 442.42M -27.5% |
| EPS | 3.63 -26.2% |
| Shares Out | n/a |
| PE Ratio | 21.90 |
| Forward PE | 18.43 |
| Dividend | 3.76 (4.71%) |
| Ex-Dividend Date | Apr 22, 2026 |
| Volume | 2,537 |
| Open | 109.00 |
| Previous Close | 106.52 |
| Day's Range | 105.64 - 109.00 |
| 52-Week Range | 84.76 - 129.00 |
| Beta | 0.54 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 3, 2026 |
About The Clorox Company
The Clorox Company manufactures and markets consumer and professional products worldwide. The company operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers home care cleaning and disinfecting products, bleach, clog removers, and laundry additives under the Clorox, Clorox2, Pine-Sol, Scentiva, Tilex, Liquid-Plumr, Poett, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service p... [Read more]
Financial Performance
In fiscal year 2026, The Clorox Company's revenue was $6.72 billion, a decrease of -5.41% compared to the previous year's $7.10 billion. Earnings were $587.00 million, a decrease of -27.53%.
Financial numbers in USD Financial StatementsNews
Clorox price target lowered to $100 from $102 at BofA
BofA lowered the firm’s price target on Clorox (CLX) to $100 from $102 and keeps a Neutral rating on the shares. FY27 EPS guidance was set “low and wide” as…
Clorox price target raised to $98 from $94 at Deutsche Bank
Deutsche Bank raised the firm’s price target on Clorox (CLX) to $98 from $94 and keeps a Hold rating on the shares.
Clorox price target raised to $95 from $92 at JPMorgan
JPMorgan analyst Andrea Teixeira raised the firm’s price target on Clorox (CLX) to $95 from $92 and keeps an Underweight rating on the shares.
Clorox price target raised to $105 from $100 at UBS
UBS raised the firm’s price target on Clorox (CLX) to $105 from $100 and keeps a Neutral rating on the shares.
Clorox price target raised to $99 from $98 at Evercore ISI
Evercore ISI raised the firm’s price target on Clorox (CLX) to $99 from $98 and keeps an Underperform rating on the shares.
Clorox price target raised to $100 from $97 at Citi
Citi analyst Filippo Falorni raised the firm’s price target on Clorox (CLX) to $100 from $97 and keeps a Neutral rating on the shares.
The Clorox Company Earnings Call Transcript: Q4 2026
FY26 saw strong execution amid inflation and value-seeking trends, with most segments meeting or exceeding expectations and targeted improvements in underperformers. FY27 guidance calls for flat to slightly up organic sales, targeted pricing, persistent inflation, and continued investment in innovation and productivity, with GOJO integration progressing well.
The Clorox Company Earnings release: Q4 2026
The Clorox Company released its Q4 2026 earnings on August 3, 2026, summarizing the period's financial results.
The Clorox Company Annual report: Q4 2026
The Clorox Company has published its Q4 2026 annual report on August 3, 2026.
Clorox Projects Tough Fiscal Year 2027 with Inflation, Value-Seeking Customers
The company now expects sales to rise between 13% and 14% for the current fiscal year after its fourth-quarter revenue fell to $1.95 billion.
Clorox forecasts upbeat annual sales as demand improves
Pine-Sol maker Clorox forecast annual sales above analysts' expectations on Monday, betting on improving demand for its health and wellness segments as well as from international customers despite m...
Clorox Reports Q4 and FY26 Results, Provides FY27 Outlook
Delivers Q4 results in line with expectations while advancing strategic investments OAKLAND, Calif., Aug. 3, 2026 /PRNewswire/ -- The Clorox Company (NYSE: CLX) today reported results for the fourth q...
Clorox increases quarterly dividend to $1.25 per share
The Clorox (CLX) Company announced that its board has declared an increase to its quarterly dividend to $1.25 per share from $1.24 on the company’s common stock. The dividend is…
Clorox Increases Quarterly Dividend to $1.25 Per Share
OAKLAND, Calif., July 31, 2026 /PRNewswire/ -- The Clorox Company (NYSE: CLX) announced today that its board of directors has declared an increase to its quarterly dividend from $1.24 to $1.25 per sha...
Clorox downgraded to Hold from Buy at Jefferies
Jefferies downgraded Clorox (CLX) to Hold from Buy with a price target of $98, down from $125. The firm admits to being wrong in assuming the company’s fiscal 2027 earnings…
Clorox price target lowered to $98 from $110 at Evercore ISI
Evercore ISI analyst Javier Escalante lowered the firm’s price target on Clorox (CLX) to $98 from $110 and keeps an Underperform rating on the shares.
Top 10 Dividend Stocks to Buy in 2026
In this bonus episode of The Morning Filter podcast, co-hosts Dave Sekera and Susan Dziubinski talk dividend stock investing. They unpack the performance of dividend stocks during the first half of 20...
Clorox Announces August 3 Webcast of Fourth-Quarter and Fiscal Year 2026 Results
OAKLAND, Calif., July 13, 2026 /PRNewswire/ -- The Clorox Company (NYSE: CLX) will issue its fourth-quarter and fiscal year 2026 results on August 3, 2026.
Why Verizon, Clorox and More Dividend Stocks Are Flashing a Buy Signal
It's the right time to jump in on dividend stocks. Clorox, Pfizer, Verizon and Comcast are some of the names to consider.
Clorox Announces Simplified Operating Structure to Improve Execution and Accelerate Growth
OAKLAND, Calif., June 17, 2026 /PRNewswire/ -- The Clorox Company (NYSE: CLX) today announced a simplified operating structure designed to streamline leadership oversight, align resources to drive the...
3 Stocks to Invest In to Rebalance Your Portfolio
#TheMorningFilter #PortfolioRebalance #StockInvesting These value stocks can balance portfolios heavy in growth stocks—and they're undervalued, too. Watch The Morning Filter: https://www.youtube.com/l...
The Clorox Company Transcript: 23rd annual dbAccess Global Consumer Conference
Leadership transition is underway with no immediate operational changes. The business is stabilizing after a major ERP upgrade, focusing on innovation and market share gains amid a volatile consumer environment. GOJO integration is progressing well, with financial discipline and digital transformation supporting future growth.
Clorox Healthcare Introduces Two Breakthrough Innovations to Help Solve Infection Prevention Challenges
Clorox Healthcare launches two new innovative products designed to help close a critical compliance gap in daily disinfection: Clorox Healthcare Quat Alcohol Disinfecting Wipes, featuring a 1-minute c...
Clorox CEO to Step Down for Health Reasons
Clorox Chief Executive Officer Linda Rendle is stepping down for health reasons after more than 20 years at the company.
Clorox Board of Directors to Initiate Comprehensive CEO Search Process
Chair and CEO Linda Rendle to Step Down Following Appointment of New CEO OAKLAND, Calif., May 28, 2026 /PRNewswire/ -- The Clorox Company (NYSE: CLX) today announced that Chair and Chief Executive Of...